We are live on ! Find out more
BBH icon

VanEck Biotech ETF
BBH

115 hedge funds and large institutions have $150M invested in VanEck Biotech ETF in 2024 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 24 increasing their positions, 32 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

23% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 13

0% more funds holding

Funds holding: 115 → 115 (0)

1% less capital invested

Capital invested by funds: $152M → $150M (-$1.49M)

25% less repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 32

40.53% less ownership

Funds ownership: 78.34% → 37.81% (-41%)

Holders
115
Holders Change
–
Holders Change %
0%
% of All Funds
1.51%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
24
Reduced
32
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
TWC
TD Waterhouse Canada
Ontario, Canada
+$10.7M
2
Bank of America
Bank of America
North Carolina
+$6.74M
3
Morgan Stanley
Morgan Stanley
New York
+$3.25M
4
ACA
Atlas Capital Advisors
Wyoming
+$959K
5
TAM
Tocqueville Asset Management
New York
+$922K

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$2.7M
2
GT
Glenview Trust
Kentucky
-$1.65M
3
Jane Street
Jane Street
New York
-$1.48M
4
MIM
Miller Investment Management
Pennsylvania
-$1.28M
5
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management
Wisconsin
-$662K
Name Holding Trade Value Shares
Change 		Change in
Stake
Two Sigma Investments
51
Two Sigma Investments
New York
$298K -$118K -700 -27%
Focus Partners Wealth
52
Focus Partners Wealth
Massachusetts
$271K +$291K +1,729 New
IWC
53
Integrated Wealth Concepts
Massachusetts
$259K +$336 +2 +0.1%
IAA
54
Independent Advisor Alliance
North Carolina
$250K +$268K +1,595 New
BFC
55
Blue Fin Capital
Rhode Island
$246K -$8.92K -53 -3%
EPAM
56
Evelyn Partners Asset Management
$235K +$252K +1,500 New
TSS
57
Two Sigma Securities
New York
$230K +$246K +1,465 New
RSWM
58
Robertson Stephens Wealth Management
California
$225K – – –
HFAS
59
Hummer Financial Advisory Services
Illinois
$221K – – –
Envestnet Asset Management
60
Envestnet Asset Management
Illinois
$221K -$309K -1,837 -57%
TSWM
61
Tyler-Stone Wealth Management
Ohio
$220K -$12.3K -73 -5%
CIBC World Market
62
CIBC World Market
Ontario, Canada
$219K -$20.2K -120 -8%
PAG
63
Private Advisor Group
New Jersey
$216K -$84.1K -500 -27%
CRI
64
Commonwealth Retirement Investments
Virginia
$215K +$231K +1,372 New
UCB
65
United Community Bank
South Carolina
$215K – – –
CB
66
Commerce Bank
Missouri
$204K – – –
CWP
67
Cyndeo Wealth Partners
Florida
$204K – – –
FTUS
68
Flow Traders U.S.
New York
$204K +$219K +1,300 New
OC
69
Oppenheimer & Co
New York
$202K -$6.73K -40 -3%
CA
70
Continuum Advisory
Idaho
$162K – – –
WSFS
71
Wilmington Savings Fund Society
Delaware
$154K +$7.74K +46 +5%
UB
72
UMB Bank
Missouri
$149K +$8.75K +52 +6%
Comerica Bank
73
Comerica Bank
Texas
$129K -$16.7K -99 -11%
NP
74
NorthRock Partners
Minnesota
$119K -$12.6K -75 -9%
Osaic Holdings
75
Osaic Holdings
Arizona
$84.4K -$8.92K -53 -9%
1 2
3
4 5

BBH Hedge Fund Activity: Q4 2024 in Review

115 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in VanEck Biotech ETF (BBH) for Q4 2024, worth a combined $150M — down 0.98% from $152M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new BBH positions and 13 closed out — a net gain of 3 holders — while 24 added to existing stakes and 32 trimmed.

The largest buyer was TD Waterhouse Canada, opening a new position worth an estimated $10.7M. The largest seller was Citadel Advisors, cutting an estimated $2.7M.

  • 115 institutional investors held VanEck Biotech ETF (BBH) as of Q4 2024, unchanged from Q3 2024.
  • Funds reported $150M of VanEck Biotech ETF stock for Q4 2024, down 0.98% quarter-over-quarter.
  • 16 funds opened new VanEck Biotech ETF positions in Q4 2024 and 13 closed out, a net change of +3 holders.
  • The largest VanEck Biotech ETF buyer in Q4 2024 was TD Waterhouse Canada, an estimated $10.7M added.
  • The largest VanEck Biotech ETF seller in Q4 2024 was Citadel Advisors, an estimated $2.7M sold.

Based on aggregated 13F filings for Q4 2024.